Results 151 to 160 of about 158,234 (188)

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors. [PDF]

J Cancer Res Clin Oncol
Jörg I, Chronas D.
europepmc   +1 more source

Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance. [PDF]

BMC Cancer
Ökten IN, Baydaş T, Koca S, Baltacı MF, Özen F, Çil İ, Eser M, Gündoğdu A, Aktaş M, Yılmaz OC.   +9 more
europepmc   +1 more source

Identifying a Recurrent BRCA1 Variant in the Qatari Population With Unique Genotype-Phenotype Correlations. [PDF]

Mol Genet Genomic Med
Bujassoum Al-Bader S, Al-Mulla H, Al-Habish H, Kusasi S, Abduo N, Bakheet N, Ghazouani H, Sidenna M, Abbaszadeh F, Alsulaiman R.   +9 more
europepmc   +1 more source

Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer. [PDF]

Mol Med
Chen L, He S.
europepmc   +1 more source

Functional assessment of protein variants in structured domains by fluorescence cross-correlation spectroscopy. [PDF]

Sci Rep
Mateu-Regué À, Mariani L, Bagger FO, Bose M, Nielsen FC.   +4 more
europepmc   +1 more source

Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review. [PDF]

Ann Surg Oncol
Liguori L, Ventin M, Cattaneo G, Zhang L, Osipov A, Sabbatino F, Ferrone CR.   +6 more
europepmc   +1 more source

The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination. [PDF]

PLoS Biol
Wang L, Wu X, Paul A, Yao J, Wang B.
europepmc   +1 more source

Hereditary ovarian cancer in women with African ancestry: a scoping review. [PDF]

Fam Cancer
Rossouw B, Araujo M, Krause A, Baine-Savanhu F.   +3 more
europepmc   +1 more source